KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Restructuring Costs: 2022-2024

Historic Restructuring Costs for Neogenomics (NEO) over the last 1 years, with Mar 2024 value amounting to $2.4 million.

  • Neogenomics' Restructuring Costs fell 48.80% to $2.4 million in Q1 2024 from the same period last year, while for Mar 2024 it was $8.8 million, marking a year-over-year change of. This contributed to the annual value of $11.1 million for FY2023, which is 145.53% up from last year.
  • Per Neogenomics' latest filing, its Restructuring Costs stood at $2.4 million for Q1 2024, which was up 99.00% from $1.2 million recorded in Q4 2023.
  • In the past 5 years, Neogenomics' Restructuring Costs ranged from a high of $4.7 million in Q1 2023 and a low of $1.2 million during Q4 2023.
  • Moreover, its 3-year median value for Restructuring Costs was $2.7 million (2023), whereas its average is $3.0 million.
  • Data for Neogenomics' Restructuring Costs shows a maximum YoY crashed of 73.32% (in 2023) over the last 5 years.
  • Over the past 3 years, Neogenomics' Restructuring Costs (Quarterly) stood at $4.5 million in 2022, then plummeted by 73.32% to $1.2 million in 2023, then slumped by 48.80% to $2.4 million in 2024.
  • Its last three reported values are $2.4 million in Q1 2024, $1.2 million for Q4 2023, and $2.1 million during Q3 2023.